Aprea Therapeutics Inc
APRE1.700USD
+0.040+2.41%
終値 08/04, 16:00（ET）15分遅れの株価
1.698USD+1.698時間外取引 08/04, 20:00 (ET)
9.37M時価総額
損失額直近12ヶ月PER
四半期
四半期+年間
四半期
年間
YOY
空白行を非表示にする
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
総売上高
-57.31%162.46K
1362.29%205.82K
11.00%354.62K
124.91%561.57K
--380.57K
--14.07K
--319.47K
--249.69K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
収益
-57.31%162.46K
1362.29%205.82K
11.00%354.62K
124.91%561.57K
--380.57K
--14.07K
--319.47K
--249.69K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
営業費用
20.33%4.25M
-6.97%3.43M
15.86%4.45M
13.00%4.41M
-23.63%3.53M
39.12%3.69M
-8.52%3.84M
-82.62%3.90M
-42.75%4.62M
-66.13%2.65M
-55.46%4.20M
124.51%22.45M
-20.75%8.07M
-44.96%7.83M
-22.92%9.43M
-30.96%10.00M
-14.17%10.19M
18.73%14.22M
69.49%12.23M
143.85%14.48M
169.36%11.87M
144.52%11.98M
146.30%7.22M
--5.94M
--4.41M
--4.90M
--2.93M
研究 & 開発費
55.16%2.48M
15.32%2.36M
34.10%2.85M
16.12%2.56M
27.36%1.60M
284.96%2.05M
89.93%2.12M
-67.66%2.20M
-69.27%1.26M
-88.09%531.41K
-81.42%1.12M
2.36%6.81M
-39.54%4.09M
-52.16%4.46M
-31.34%6.02M
-37.78%6.65M
-25.64%6.76M
15.99%9.33M
78.42%8.76M
147.56%10.69M
147.28%9.10M
82.98%8.04M
112.85%4.91M
--4.32M
--3.68M
--4.39M
--2.31M
減価償却費、減耗費および償却費
-11.82%5.43K
8.86%5.43K
279.12%5.43K
2267.86%5.30K
1401.71%6.16K
--4.99K
-97.67%1.43K
-99.65%224.00
-99.36%410.00
----
-11.63%61.37K
5.74%63.69K
-16.10%63.77K
15.99%65.99K
22.50%69.44K
24.83%60.24K
12.14%76.00K
9.72%56.89K
-8.28%56.69K
1757.43%48.26K
142.72%67.77K
2788.86%51.85K
2637.25%61.81K
--2.60K
--27.92K
--1.79K
--2.26K
営業利益
-29.71%-4.09M
12.21%-3.23M
-16.30%-4.10M
-5.35%-3.85M
31.86%-3.15M
-38.59%-3.67M
16.13%-3.52M
83.73%-3.65M
42.75%-4.62M
66.13%-2.65M
55.46%-4.20M
-124.51%-22.45M
20.75%-8.07M
44.96%-7.83M
22.92%-9.43M
30.96%-10.00M
14.17%-10.19M
-18.73%-14.22M
-69.49%-12.23M
-143.85%-14.48M
-169.36%-11.87M
-144.52%-11.98M
-146.30%-7.22M
---5.94M
---4.41M
---4.90M
---2.93M
営業外受取（支払）利息純額
営業外受取利息
-27.76%204.73K
-11.49%274.63K
8.57%348.74K
13.73%382.37K
10.53%283.40K
27.65%310.29K
112.55%321.21K
540.53%336.22K
12909.13%256.41K
--243.08K
--151.12K
--52.49K
--1.97K
----
----
----
----
-97.21%4.74K
----
--2.68K
--224.44K
8494300.00%169.89K
----
----
----
--2.00
--4.00
営業外支払利息
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--33.00
--588.00
--1.06K
----
----
----
----
----
--6.10K
--4.09K
--3.35K
----
----
有価証券売却益
-192.22%-51.80K
172.02%56.62K
-1132.43%-35.49K
-109.76%-5.50K
507.16%56.18K
-133.99%-78.61K
-111.83%-2.88K
-63.53%56.36K
-110.13%-13.80K
-147.88%-33.60K
211.17%24.35K
161.13%154.57K
-73.91%136.21K
105.98%70.17K
70.62%-21.91K
86.62%-252.84K
-76.78%521.98K
7.05%-1.17M
-107.65%-74.56K
-377.87%-1.89M
140.18%2.25M
-674.81%-1.26M
569.80%975.03K
--680.06K
--935.92K
--219.70K
---207.54K
特別利益（損失）
----
----
----
----
----
--0.00
--0.00
100.00%0.00
----
--0.00
--0.00
---76.02M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
税引前利益
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
-2.86%-9.67M
-17.75%-15.39M
-97.11%-12.32M
-211.03%-16.37M
-170.50%-9.40M
-179.35%-13.07M
-99.14%-6.25M
---5.26M
---3.48M
---4.68M
---3.14M
法人税等
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
税引後利益
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
-2.86%-9.67M
-17.75%-15.39M
-97.11%-12.32M
-211.03%-16.37M
-170.50%-9.40M
-179.35%-13.07M
-99.14%-6.25M
---5.26M
---3.48M
---4.68M
---3.14M
継続事業による純利益
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
-2.86%-9.67M
-17.75%-15.39M
-97.11%-12.32M
-211.03%-16.37M
-170.50%-9.40M
-179.35%-13.07M
-99.14%-6.25M
---5.26M
---3.48M
---4.68M
---3.14M
親会社株主に帰属する当期純利益
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
-2.86%-9.67M
-17.75%-15.39M
-97.11%-12.32M
-211.03%-16.37M
-170.50%-9.40M
-179.35%-13.07M
-99.14%-6.25M
---5.26M
---3.48M
---4.68M
---3.14M
普通株主に帰属する純利益
-39.95%-3.93M
15.93%-2.89M
-18.08%-3.78M
-6.47%-3.47M
35.84%-2.81M
-40.99%-3.44M
20.38%-3.20M
96.68%-3.26M
44.81%-4.38M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
49.62%-7.76M
23.26%-9.45M
37.37%-10.25M
-2.86%-9.67M
-17.75%-15.39M
-97.11%-12.32M
-211.03%-16.37M
-170.50%-9.40M
-179.35%-13.07M
-99.14%-6.25M
---5.26M
---3.48M
---4.68M
---3.14M
基本的1株当たり利益
1.98%-0.66
47.25%-0.49
25.75%-0.64
33.08%-0.58
50.17%-0.67
-0.34%-0.92
63.06%-0.86
98.99%-0.87
81.47%-1.34
87.25%-0.92
73.92%-2.32
-796.14%-86.72
20.59%-7.25
50.44%-7.20
23.43%-8.90
37.61%-9.68
-2.21%-9.13
-47.77%-14.53
-78.72%-11.63
-183.07%-15.51
-146.81%-8.93
-101.82%-9.83
-99.13%-6.51
---5.48
---3.62
---4.87
---3.27
希薄化後1株当たり利益
1.98%-0.66
47.25%-0.49
25.75%-0.64
33.08%-0.58
50.17%-0.67
-0.34%-0.92
63.06%-0.86
98.99%-0.87
81.47%-1.34
87.25%-0.92
73.92%-2.32
-796.14%-86.72
20.59%-7.25
50.44%-7.20
23.43%-8.90
37.61%-9.68
-2.21%-9.13
-47.77%-14.53
-78.72%-11.63
-183.07%-15.51
-146.81%-8.93
-101.82%-9.83
-99.13%-6.51
---5.48
---3.62
---4.87
---3.27
1株当たり配当金
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
通貨単位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
監査意見
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
